Clinical trial
High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
NCT00212901 · Ottawa Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00212901 |
|---|---|
| Title | High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy |
| Official title | Addition of Angiotensin Receptor Blockade to ACE Inhibition Versus High Dose ACE Inhibition for Reduction of Proteinuria in Patients With Diabetic Nephropathy |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetic Kidney Disease |
| Intervention type | Drug |
| Interventions | High dose ACE-I vs ARB |
| Enrollment | 30 |
| Start date | Aug 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 26, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: